HuGE Literature Finder
Records
1
-
15
| Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors. Frontiers in genetics 2021 8 12 699910. Liu Donghui, Wang Xuyao, Shi Enhong, Wang Liru, Nie Minghao, Li Long, Jiang Qingxin, Kong Pengyu, Shi Shuai, Wang Chao, Yan Sen, Qin Zhihui, Zhao Shua |
| KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. American journal of cancer research 2021 1 10 (12): 4464-4475. Zhang Xiaoshan, Zhang Ran, Chen Huiqin, Wang Li, Ren Chenghui, Pataer Apar, Wu Shuhong, Meng Qing H, Ha Min Jin, Morris Jeffrey, Xi Yuanxin, Wang Jing, Zhang Jianhua, Gibbons Don L, Heymach John V, Meric-Bernstam Funda, Minna John, Swisher Stephen G, Roth Jack A, Fang Binglia |
| Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: A genotype-phenotype study. Gene 2019 12 728 144281. Al-Eitan Laith N, Rababa'h Doaa |
| SMYD3 promoter hypomethylation is associated with the risk of colorectal cancer. Future oncology (London, England) 2018 7 14 (18): 1825-1834. Li Bin, Pan Ranran, Zhou Cong, Dai Jie, Mao Yiyi, Chen Min, Huang Tianyi, Ying Xiuru, Hu Haochang, Zhao Jun, Zhang Wei, Duan Shiw |
| Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis. Bioscience reports 2017 Oct . Ma Shao-Jun, Liu Yan-Mei, Zhang Yue-Lang, Chen Ming-Wei, Cao W |
| SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer. Medical science monitor : international medical journal of experimental and clinical research 2016 Dec 22 5131-5140. Liu Ting-Ting, Xu Hui, Gao Wei-Ping, Zhang Shu-Xiang, Zhou Xu-Hong, Tang Juan, Liu Qiong- |
| SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma. Human pathology 2016 3 52 153-63. Zhu Ying, Zhu Meng-Xiao, Zhang Xiao-Dan, Xu Xiu-E, Wu Zhi-Yong, Liao Lian-Di, Li Li-Yan, Xie Yang-Min, Wu Jian-Yi, Zou Hai-Ying, Xie Jian-Jun, Li En-Min, Xu Li-Y |
| Smyd3-associated regulatory pathways in cancer. Seminars in cancer biology 2016 8 42 70-80. Giakountis Antonis, Moulos Panagiotis, Sarris Michalis E, Hatzis Pantelis, Talianidis Iann |
| High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. Human pathology 2012 3 43 (9): 1425-35. He Chuanchao, Xu Junyao, Zhang Jianlong, Xie Dan, Ye Hua, Xiao Zhiyu, Cai Muyan, Xu Kang, Zeng Yunjie, Li Haigang, Wang J |
| Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer. Anticancer research 2011 12 31 (12): 4115-25. Patani Neill, Jiang Wen G, Newbold Robert F, Mokbel Kef |
| Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking. Cancer science 2008 Apr 99 (4): 787-91. Wang Haijian, Liu Yang, Tan Wen, Zhang Yang, Zhao Naiqing, Jiang Yan, Lin Chengzhao, Hao Bingtao, Zhao Dan, Qian Ji, Lu Daru, Jin Li, Wei Qingyi, Lin Dongxin, He Fuc |
| SMYD3 tandem repeats polymorphism is not associated with the occurrence and metastasis of hepatocellular carcinoma in a Chinese population. Experimental oncology 2007 Mar 29 (1): 71-3. Wang X Q, Miao X, Cai Q, Garcia-Barcelo M M, Fan S |
| Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. Oncology reports 2007 12 19 (1): 257-62. Xi Yaguang, Formentini Andrea, Nakajima Go, Kornmann Marko, Ju Jingfa |
| A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers. Nature genetics 2005 Oct 37 (10): 1104-7. Tsuge Masataka, Hamamoto Ryuji, Silva Fabio Pittella, Ohnishi Yozo, Chayama Kazuaki, Kamatani Naoyuki, Furukawa Yoichi, Nakamura Yusu |
| Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer. International journal of cancer 2005 12 118 (11): 2917-8. Frank Bernd, Hemminki Kari, Wappenschmidt Barbara, Klaes Rüdiger, Meindl Alfons, Schmutzler Rita K, Bugert Peter, Untch Michael, Bartram Claus R, Burwinkel Barba |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: